School of Medicine
Showing 3,251-3,300 of 4,373 Results
-
Jorge Roa
Software Developer Associate, Health Policy
BioJorge Roa is a software developer and data scientist in the Department of Health Policy at Stanford University. Prior to joining Stanford, Jorge completed a research fellowship in the Department of Statistics at the University of Munich. He holds an M.Sc. in Data Science for Public Policy from the Hertie School in Berlin, Germany. Jorge earned a B.A. in Public Policy from the Center for Research and Teaching in Economics (CIDE) in Aguascalientes, Mexico. His work has focused on gastric and colorectal cancer research, helping apply Bayesian methods and decision-analytic models, as well as creating and optimizing algorithms. He also has experience in developing and implementing open-source R packages. Jorge is part of the colorectal cancer group within the Cancer Intervention and Surveillance Modeling Network (CISNET). His research centers on employing data science tools and decision-analytic models to make informed decisions based on data and evidence to improve people’s lives.
-
Jennifer Robinson
Associate Director, Medicine - Med/Stanford Prevention Research Center
Current Role at StanfordAssociate Director, Nutrition Studies Group
-
Alexandre Rodrigues Marra
Contingent Employee, Medicine - Med/Infectious Diseases
Current Role at StanfordResearcher
-
Daniela Rodriguez Martinez
Assistant Manager, Communications, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Manager, Communications @Stanford Byers Center for Biodesign
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox).
